Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
12/14/2000 | CA2374558A1 Phospholipid transfer protein |
12/14/2000 | CA2371434A1 Compositions and methods for the treatment of tumor |
12/14/2000 | CA2336590A1 Hybrid yeast-bacteria cloning system and uses thereof |
12/13/2000 | EP1059353A2 Novel calpain and dna encoding the same |
12/13/2000 | EP1058732A2 Attenuation of bacteria: materials and methods relating thereto |
12/13/2000 | EP1058730A1 Human synapse related glycoproteins (hsrp) |
12/13/2000 | EP1058728A1 V-like domain binding molecules |
12/13/2000 | EP1058726A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
12/13/2000 | EP1058725A1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
12/13/2000 | EP1058724A1 Maltogenic alpha-amylase variants |
12/13/2000 | EP1058723A1 Delivery of proteins into eukaryotic cells with recombinant yersinia |
12/13/2000 | EP1058500A1 The helios gene |
12/13/2000 | CN1276834A Modified nucleic acid sequences and method for increasing mRNA level and protein expression in cell system |
12/13/2000 | CN1276833A Vaccine |
12/13/2000 | CN1276832A Composition and method for identifying PKB kinase inhibitors |
12/13/2000 | CN1276831A Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems |
12/13/2000 | CN1276830A Single-stranded antibody against hepatitis B virus core protein, gene thereof, and therapeutic agent for hepatitis B contg. these |
12/13/2000 | CN1276797A Low-toxicity human interferon-alpha analog |
12/13/2000 | CN1276791A Macrolides with antitumor activity |
12/13/2000 | CN1276771A Method for reducing effect of detergents upon germination and/or growth of microorganisms |
12/13/2000 | CN1276729A Heparin-binding growth factor (HBGF) polypeptides |
12/13/2000 | CN1276429A Clone of rice Xanthomonas hrp gene and regulatory gene of hrp gene |
12/13/2000 | CN1276421A Method for production of L-arginine |
12/13/2000 | CN1276198A Process for preparing needle-shaped reeds for growing fungus to save wood and its product |
12/13/2000 | CN1059464C New strain of orange monascus and its application |
12/13/2000 | CN1059463C New strains of monascus purpureus, monascus and their application |
12/13/2000 | CN1059462C Method for producing hedgehog hydnum |
12/12/2000 | US6160206 Porphyrin-accumulating type herbicide resistance gene |
12/12/2000 | US6160205 Transgenic plant cell with increased disease resistance |
12/12/2000 | US6160108 Platelet activation protein |
12/12/2000 | US6160099 Anti-human αv β3 and αv β5 antibodies |
12/12/2000 | US6160091 Transcription factor; for the treatment of genetic disorders; for gene therapy |
12/12/2000 | US6160089 Cellular signal for the expression of mammalian somatotropin; for the amplification of somatotropin in cells |
12/12/2000 | US6159949 Polynucleotides, codes and amino acid sequences |
12/12/2000 | US6159732 Nucleic acid encoding mammalian Ubr1 |
12/12/2000 | US6159725 Transformed yeast strains |
12/12/2000 | US6159724 Making medium free of chemical additives by starting with two dilute aqueous mixtures of yeast autolysate and whole-meal or wheat germ which contain starch and either gluten or proteins, hydrolyzing with enzymes, and mixing the two products together |
12/12/2000 | US6159722 First catalytic domain half of a factor xa linked to the second catalytic domain half of trypsin; anticoagulants with reduced side effects |
12/12/2000 | US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease |
12/12/2000 | US6159708 Chaperone expression plasmids |
12/12/2000 | US6159705 Screening by using yeast cell which expresses a heterologous receptor which is functionally integrated into an endogenous yeast signaling pathway, contacting with a test compound, and detecting alteration in signal |
12/12/2000 | US6159700 Method of finding agonist and antagonist to human and rat GPR14 |
12/12/2000 | US6159696 Isolated human BMP-4 promoter region |
12/12/2000 | US6159465 Epithelial adhesive lactobacilli |
12/12/2000 | US6159463 Lymphocyte chemoattractant factor |
12/12/2000 | CA2044721C Preparation and use of enzyme-detergent extracted streptococcus zooepidemicus vaccine |
12/12/2000 | CA2014948C Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity |
12/12/2000 | CA1341153C Hybrid bacillus thuringiensis gene, plasmid, and transformed pseudomonas fluorescens |
12/12/2000 | CA1341152C Receptor protein for human b cell stimulatory factor-2 |
12/09/2000 | CA2308691A1 Live attenuated bacteria for use in a vaccine |
12/07/2000 | WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor |
12/07/2000 | WO2000073794A2 Method for separating cells using immunorosettes |
12/07/2000 | WO2000073508A1 Methods and compositions for isolating high molecular weight dna from natural samples |
12/07/2000 | WO2000073502A2 Essential genes and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections |
12/07/2000 | WO2000073495A1 Culture medium for detection of dekkera and brettanomyces |
12/07/2000 | WO2000073494A1 Culture medium for the detection of zygosaccharomyces |
12/07/2000 | WO2000073476A1 Vector for integration of heterologous sequences into poxviral genomes |
12/07/2000 | WO2000073472A1 Vector containing polysaccharide degrading enzyme gene as a selection marker, host transformed therewith, method for selecting transformant, medium for selecting the transformant and method of producing medium thereof |
12/07/2000 | WO2000073469A2 Protein kinases |
12/07/2000 | WO2000073468A1 Novel murine and human kinases |
12/07/2000 | WO2000073463A1 Groel muteins with improved stability |
12/07/2000 | WO2000073462A2 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use |
12/07/2000 | WO2000073459A1 Four-helical bundle protein zsig81 |
12/07/2000 | WO2000073458A1 Secreted alpha-helical protein-31 |
12/07/2000 | WO2000073456A1 A VARIANT OF C6 β-CHEMOKINE LEUKOTACTIN-1(shLkn-1) WITH ENHANCED BIOLOGICAL ACTIVITY |
12/07/2000 | WO2000073455A1 Biosynthesis of foreign proteins using transformed microalgae |
12/07/2000 | WO2000073453A1 T-bet compositions and methods of use thereof |
12/07/2000 | WO2000073451A1 Mammalian receptor proteins; related reagents and methods |
12/07/2000 | WO2000073450A2 Cytoskeleton-associated proteins |
12/07/2000 | WO2000073448A1 Adipocyte complement related protein homolog zacrp7 |
12/07/2000 | WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3) |
12/07/2000 | WO2000073444A1 Adipocyte complement related protein homolog zacrp5 |
12/07/2000 | WO2000073443A1 Lipid metabolism transcription factor |
12/07/2000 | WO2000073428A1 Novel endo-beta-1,4-glucanases |
12/07/2000 | WO2000073414A1 Bacteria transformation kit |
12/07/2000 | WO2000073413A2 Apparatus and method for cell disruption |
12/07/2000 | WO2000073412A2 Apparatus and method for analyzing a fluid sample |
12/07/2000 | WO2000073349A1 Dr4 antibodies and uses thereof |
12/07/2000 | WO2000073348A2 Methods and compositions for inhibiting neoplastic cell growth |
12/07/2000 | WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
12/07/2000 | WO2000073334A2 Human sorting nexins |
12/07/2000 | WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation |
12/07/2000 | WO2000073323A2 Adam polynucleotides and polypeptides |
12/07/2000 | WO2000073321A1 Human tumor necrosis factor receptor tr10 |
12/07/2000 | WO2000073319A1 Method for enhanced protein stabilization and production of cell lines useful for production of such stabilized proteins |
12/07/2000 | WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
12/07/2000 | WO2000072650A2 Compositions and methods for bioremediation |
12/07/2000 | WO2000047727A3 Nucleic acid molecules encoding alternansucrase |
12/07/2000 | WO2000046391A3 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
12/07/2000 | WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens |
12/07/2000 | WO2000043519A3 Neisseria meningitidis polypeptides |
12/07/2000 | WO2000042561A3 Oligonucleotide mediated nucleic acid recombination |
12/07/2000 | WO2000042205A3 Herbicide target gene and methods |
12/07/2000 | WO2000031247A3 Recombinant methods and materials for producing epothilone and epothilone derivatives |
12/07/2000 | CA2414214A1 Four-helical bundle protein zsig81 |
12/07/2000 | CA2385822A1 Essential gene and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections |
12/07/2000 | CA2383244A1 Protein kinases |
12/07/2000 | CA2378737A1 Adipocyte complement related protein homolog zacrp5 |
12/07/2000 | CA2377144A1 Culture medium for detection of dekkera and brettanomyces |
12/07/2000 | CA2376116A1 Promotion or inhibition of angiogenesis and cardiovascularization |